Wilmer Cutler Pickering Hale and Dorr advised Astria Therapeutics, Inc., and Cooley advised the underwriters. Astria Therapeutics, Inc. (Astria) (Nasdaq: ATXS) announced it completed its underwritten registered...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised IDEAYA Biosciences, Inc. on the offering, and Davis Polk & Wardwell advised Jefferies LLC, as sales agent. IDEAYA Biosciences, Inc. (NYSE: IDYA)...
You must be a Standard 1 Year member to access this content.
Homburger advised Jefferies LLC and Leerink Partners LLC on the deal. AC Immune SA, a Swiss clinical stage biopharmaceutical company pioneering in precision medicine for neurodegenerative...
You must be a Standard 1 Year member to access this content.
Simpson Thacher & Bartlett advised Gates Industrial Corporation plc on the offering, and Davis Polk & Wardwell advised the representative of the underwriters. Gates Industrial Corporation...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler advised Celldex Therapeutics, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriters. Celldex Therapeutics, Inc. (Nasdaq: CLDX) (“Celldex”) announced the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Latham & Watkins advised CARGO Therapeutics, Inc. on the offering, and Cooley advised the underwriters. CARGO Therapeutics, Inc. (CARGO) (Nasdaq:CRGX)...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised IDEAYA Biosciences, Inc. on the offering, and Davis Polk & Wardwell advised the representatives of the several underwriters. IDEAYA Biosciences, Inc. (NASDAQ:IDYA)...
You must be a Standard 1 Year member to access this content.
Simpson Thacher & Bartlett advised CSG Systems International, Inc., and Davis Polk & Wardwell advised the representatives of the initial purchasers on the offering. CSG Systems...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises on Arhaus’ secondary offering of class A common stock by selling stockholders. Arhaus, Inc. (Nasdaq: ARHS), a rapidly growing lifestyle brand and...
You must be a Standard 1 Year member to access this content.
Cooley advised Gracell Biotechnologies; and Davis Polk & Wardwell advised the placement agents on the deal. Gracell Biotechnologies Inc. (Nasdaq: GRCL) announced that it has entered into a...
You must be a Standard 1 Year member to access this content.
Foley & Lardner advised Regency Centers Corporation, Sullivan & Cromwell represented the sales agent and Davis Polk & Wardwell represented the forward purchasers in the offering....
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Recursion Pharmaceuticals, Inc.; and Davis Polk & Wardwell LLP advised Jefferies LLC, as sales agent, in the offering. Recursion Pharmaceuticals,...
You must be a Standard 1 Year member to access this content.
